Congressional Research Service LSB10009
UPDATE: All Eyes on Allergan: Drug Company’s Unprecedented Move Raises Questions for Patent and Drug Law (Part I)
Source-supplied metadata for version 8, published Mar 16, 2018.
Source-supplied fields
Report metadata
- Identifier
- LSB10009
- Version
- 8
- Product type
- Posts
- Status
- Archived
- Published
- Mar 16, 2018
- Source updated
- Jun 21, 2025, 3:19 am UTC
Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.
Structured Congress.gov references
Related federal bills
No structured bill reference is present in the hydrated Congress.gov metadata cache.